Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke

Neurological Research

Volumn 33, Issue 5, 2011, Pages 494-502

  Ma, Li ^a   Gao, Pei Yi ^a   Hu, Qing Mao ^b,c   Lin, Yan ^a   Jing, Li Na ^a   Xue, Ing ^a   Chen, Zhi Jun ^b   Wang, Yong Jun ^a   Liu, Mei li ^d   Cai, Ye Feng ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^d Tianjin Huanhu Hospital   (China)

Author keywords

Diffusion weighted; Magnetic resonance imaging; Outcome assessment; Stroke

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; RADIOLOGICAL PARAMETERS; RANKIN SCALE; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; AGED; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 79958714153     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164111X13007856084124     Document Type: Article

References (27)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
2. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA stroke study. Neurology 2000;55:1649-55.
3. Ringleb PA, Schellinger PD, Scheranz C, Hacke W. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke useful or harmful? Stroke 2002;33:1437-41.
4. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141-50.
5. Hjort N, Butcher K, Davis SM. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005;36:388-97.
6. Albers GW, Thijs VN, Wechsler L. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17.
7. Wechsler LR, Roberts R, Furlan AJ, Higashida RT, Dillon W, Roberts H, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-9.
8. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, et al. Selection of acute ischemic stroke patients for intra arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925-31.
9. Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, et al. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2009;40:1780-5.
10. Schellinger PD, Fiebach JB, Jansen O, Ringleb PA, Mohr A, Steiner T, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 2001;49:460-9.
11. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, et al. Diffusion and perfusion MRI-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28-37.
12. Kidwell CS, Alger JR, Saver JL. Beyond mismatch evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729-35.
13. Röther J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, et al. Effect of intravenous thrombolysis on MRIparameters and functional outcome in acute stroke,6 hours. Stroke 2002;33:2438-45.
14. Nighoghossian N, Hermier M, Adeleine P, Derex L, Dugor JF, Philippeau F, et al. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003;34:458-63.
15. Ma L, Gao PY, Hu QM, Lin Y, Jing LN, Xue J, Wang XC, et al. Prediction of infarct core and salvageable ischemic tissue volumes by analyzing apparent diffusion coefficient without intravenous contrast material. Acad Radiol 2010;17:1506-17.
16. Rosso C, Montiel NH, Deltour S. Prediction of infarct growth based on apparent diffusion coefficients: penumbral assessment without intravenous contrast material. Radiology 2009;250:184-92.
17. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002;33:79-86.
18. Hu QM, Gao PY, Ma L, Chen Z, Wu J, Ma X. Assessing the existence of ischemic penumbra through automatically analyzing baseline diffusion-weighted imaging. J Cerebr Blood Flow Metab 2009;29:S600-1.
19. Ma L, Gao PY, Lin Y, Xue J, Wang XC, Wang YJ, et al. Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator(rt-PA) thrombolysis beyond 3 hours? Neurol Res 2009;31:355-61.
20. Fiehler J, Foth M, Kucinski T, Knab R, von Bezold M, Weiller C, Zeumer H, et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002;33:79-86.
21. Kucinski T, Naumann D, Knab R, Schoder V, Wegener S, Fiehler J, et al. Tissue at risk is overestimated in perfusionweighted imaging: MR imaging in acute stroke patients without vessel recanalization. AJNR 2005;26:815-9.
22. Coutts SB, Simon JE, Tomanek AI, Barber PA, Chan J, Hudon ME, et al. Reliability of assessing percentage of diffusionperfusion mismatch. Stroke 2003;34:1681-5.
23. Desmond PM, Lovell AC, Rawlinson AA, Parsons MW, Barber PA, Yang Q, et al. The value of apparent diffusion coefficient maps in early cerebral ischemia. AJNR 2001;22:1260-7.
24. Oppenheim C, Grandin C, Samson Y, Smith A, Duprez T, Marsault C, et al. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke? Stroke 2001;32:2486-91.
25. Fiehler J, Knab R, Reichenbach JR, Fitzek C, Weiller C, Rö ther J. Apparent diffusion coefficient decreases and magnetic resonance imaging perfusion parameters are associated in ischemic tissue of acute stroke patients. J Cereb Blood Flow Metab 2001;21:577-84.
26. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
27. Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828-33.